We also established intraperitoneal xenografts for BG1 and OVCAR4 cell lines (both are MSLNlow) with and without MSLN overexpression and observed again that tumor burden and dissemination was enhanced through MSLN overexpression (Fig. S9). The gene discussed is MSLN; the disease is neoplasm.